Lindy Biosciences
Research Triangle Park, US · Founded 2016 · Delaware corporation · 1 known investors
Lindy Biosciences develops a dehydration technology that produces suspensions of highly concentrated proteins, enabling higher drug dosing in smaller volumes for subcutaneous delivery. The company focuses on drug delivery to reduce the time patients spend administering medication.
Founders & leadership
KL
Karen LeVertExecutive Officer, Director
SG
Sreekar GaddeDirector
DB
Deborah BitterfieldExecutive Officer, Director, Promoter
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$1.7MraisedMar 2024 · 10 investors · BiotechnologyRule 506(b)
▶$1.7MraisedMar 2024 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Karen LeVertDirector
- Omar FloresExecutive Officer, Director
- Deborah BitterfieldExecutive Officer, Director, Promoter
- Joel WhitleyDirector
- Offering amount
- $2.5M
- Amount sold
- $1.7M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedMar 2022 · 29 investors · BiotechnologyRule 506(b)
▶$3.3MraisedMar 2022 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Karen LevertDirector
- Omar FloresDirector
- Deborah BitterfieldExecutive Officer, Director, Promoter
- Sreekar GaddeDirector
- Offering amount
- $5M
- Amount sold
- $3.3M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$547.7KraisedJan 2019 · 6 investors · BiotechnologyRule 506(b)
▶$547.7KraisedJan 2019 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Karen LeVertExecutive Officer, Director
- Sreekar GaddeDirector
- Deborah BitterfieldExecutive Officer, Director, Promoter
- Offering amount
- $1.6M
- Amount sold
- $547.7K
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$150KraisedMar 2018 · 1 investors · BiotechnologyRule 506(b)
▶$150KraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Karen LeVertDirector
- Deborah BitterfieldExecutive Officer, Director, Promoter
- Offering amount
- $150K
- Amount sold
- $150K
- First sale
- Mar 2018
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.